Fragments 2011 - Third RSC-BMCS Fragment-based Drug Discovery meeting

Topics: Biochemistry, Medicinal Chemistry, Keywords:

Date: /7/8/ March 2011, Stevenage, United Kingdom, Europe

Web Site, Contact: maggi [at] maggichurchouseevents.co.uk (Mrs. Maggi Churchouse)

  

Official Information:

Synopsis

The aim of the 3rd RSC-BMCS Fragment-based Drug Discovery meeting will be to continue the focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programmes. These case studies will include successful examples from all types of fragment-based approaches, including high concentration, NMR, SPR and X-ray screening.

Call for Posters

The call for posters is now open, and a template is available from the secretariat. Closing date for submissions is 31st January 2011

Who should attend?

This conference is suitable for scientists from any discipline with an interest in expanding their knowledge and experience of FBDD.

Confirmed Speakers

• Ian Collins, Institute of Cancer Research
• Miles Congreve, Heptares
• Tony Giannetti, Genentech
• Colin Groom, CCDC
• Rich Law, Evotec
• Andrew Leach, GlaxoSmithKline
• Chris Murray, Astex Therapeutics
• Iva Navratilova, University of Dundee
• Peter Ray, Organon
• Gisbert Schneider, ETH
• Allen Yu-Sen Wang, Merck
• Jane Withka, Pfizer
• Denis Zeyer, NovAlix

Features

This two-day conference will include a scientific poster display, trade exhibition and conference dinner

Exhibition Opportunities

Please contact the Secretariat to be included in the trade exhibition

Students

Discounted rates will be offered to RSC student members